Fdasia support - advanced generic drug and drug quality capabilities
Ended Awarded Last action
- Contract number
- 75F40120F19005
- Awardee
-
Booz Allen Hamilton Inc. UEI JCBMLGPE6Z71 Part of Booz Allen Hamilton Holding Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $6,467,825
Award facts
- Opportunity
-
- FDA20RFQ1222104 Solicitation number
- Contract value 68% obligated
-
- $6,467,825.18 Current, with exercised options
- $9,467,186.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$3,868 | |
| Other Administrative Action | $3,298,992 | |
| Original award | $3,172,701 |
About this award
Booz Allen Hamilton Inc. was awarded a $9.5 million contract by the Department of Health and Human Services' Food and Drug Administration to provide support services relating to advanced generic drug and drug quality capabilities. This contract was awarded under the prime vendor's existing FDA Safety And Innovation Act Support Services Blanket Purchase Agreement to deliver IT consulting, business analysis, data analysis and low-code software platform services in furtherance of FDA programs outlined in the Food and Drug Administration Safety and Innovation Act. Major subcontractors include Emprata LLC for IT and data analysis support and Appian Corporation for professional services on its low-code platform. The base period of performance is from June 2020 through June 2022 in Silver Spring, Maryland.
Quick answers
Who was awarded contract 75F40120F19005?
75F40120F19005 was awarded to Booz Allen Hamilton Inc. by Food and Drug Administration (Department of Health and Human Services) on June 23, 2020.
How much is contract 75F40120F19005 worth?
The government has obligated $6,467,825 on 75F40120F19005. Its potential value, with all options, is $9,467,186.
Is contract 75F40120F19005 an order under another contract?
Yes. 75F40120F19005 is a BPA call under GS00F008DA-HHSF223201610017B, a blanket purchase agreement, on FDA Safety And Innovation Act Support Services (FDASIA).
Was contract 75F40120F19005 competed?
The extent of competition for 75F40120F19005 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award